Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Anti-Reflective Technology Development

24 Feb 2012 07:00

RNS Number : 0290Y
Oxford Advanced Surfaces Group PLC
24 February 2012
 



 

Oxford Advanced Surfaces

("OAS", or the "Company")

Further progress in Anti-Reflective Coatings for LCD displays including nanoparticle development

Nanoparticle development drives VISARC technology offering with industry-leading performance anti-reflective coatings for use on LCD / LED display screens and other high-volume markets

Oxford Advanced Surfaces Group Plc (AIM: OXA), the AIM-listed advanced materials licensing company has delivered VISARCTM coated samples to a number of potential original equipment manufacturers (OEM) and end customers showing optical performance of 0.3% reflection. The company has also delivered samples of the base nanoparticle to market leading formulators for testing their integration into proprietary binder systems that would form the basis of commercial anti reflective coatings (ARCs).

The measured performance exceeds the current industry target of 0.5% reflectance and the 1.0% reflectance seen on current commercial products when applied on a Tri acetyl cellulose (TAC) surface.

Sales and Marketing Director, Mike Edwards said,

"Our VISARC technology is unique in that it can be adapted to multiple surfaces such as glass, polycarbonate and other plastics and is showing industry-beating performance in the displays area. This technology can also be used in other markets such as solar panels, ophthalmic and other niche applications.

The anti-reflective coating market is forecasted to be in the order of $2B by 2015 and the explosive growth of tablet PCs, large screen TV and large-screen mobile phones has fuelled the demand for high-performance ARC's.

Our decision to develop our own particle has been instrumental in speeding up the sampling process. As a result we are currently engaged in a number of specific, detailed process discussions following the evaluation of our base coating and nanoparticle sample submissions."

Contact:

Oxford Advanced Surfaces Group Plc

www.oxfordsurfaces.com

Mike Edwards, Sales & Marketing Director

Philip Spinks, Chief Financial Officer

Tel: +44 (0) 1865 854 807

W H Ireland Limited

www.wh-ireland.co.uk

John Wakefield / Marc Davies

Tel: +44 (0) 117 945 3471

Public Relations:

Lothbury Financial Services

Simon Astley/Gary Middleton/Michael Padley

Tel: +44 (0) 207 868 2010

 

Editors' Note

Oxford Advanced Surfaces Group plc (OAS) is a research-based company that develops and licenses intellectual property and products in the areas of highly reactive chemistry and anti-reflective coatings. The Company's research scientists develop innovative solutions in advanced materials and nano-technology for partners to exploit. The Company's solutions apply to real-world, practical processing and innovation challenges as novel polymer and organic materials are introduced to improve cost, weight, space and performance in new products. Initial applications include advanced adhesion, anti-reflective coatings and particle delivery in markets including conventional and plastic electronics, optics, displays, batteries and solar.

 

 

 

www.oxfordsurfaces.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGZZVFVGZZM
Date   Source Headline
22nd Mar 201910:39 amRNSHolding(s) in Company
20th Mar 20197:00 amRNSDirectors' Shareholdings
19th Mar 20194:52 pmRNSReplacement - Total Voting Rights and Notice of...
19th Mar 20193:35 pmRNSHolding(s) in Company
19th Mar 20193:32 pmRNSHolding(s) in Company
15th Mar 20198:10 amRNSTotal Voting Rights and Notice of Results
12th Mar 20197:00 amRNSGrant of Options
11th Mar 201912:58 pmRNSResult of Meeting & Directorate Change
7th Mar 20199:00 amRNSIssue of Equity
25th Feb 20197:00 amRNSAcquisition, Placing & Waiver of Rule 9
14th Feb 20193:58 pmRNSHolding(s) in Company
6th Feb 20194:42 pmRNSHolding(s) in Company
6th Feb 20194:41 pmRNSHolding(s) in Company
17th Jan 20197:00 amRNSDisposal of SICM business
20th Dec 20187:00 amRNSUpdate, Conditional Acquisition & Proposed Placing
30th Nov 20187:00 amRNSPublication of Paper in leading Journal
6th Sep 20183:06 pmRNSExercise of Options and Issue of Equity
6th Sep 20187:00 amRNSInterim Results
15th Aug 20187:00 amRNSFurther Pioneer Agreements and Notice of Results
19th Jul 20187:00 amRNSPublication of Scientific Paper
11th Jun 20187:00 amRNSDirectorate Changes
11th Jun 20187:00 amRNSIssue of Equity
16th May 201811:45 amRNSResult of AGM, name change and new website
24th Apr 20187:00 amRNSDirector Dealing
19th Apr 20187:00 amRNSSecond Pioneer Agreement Signed
12th Apr 20187:00 amRNSFirst Pioneer Agreement Signed
5th Apr 20183:28 pmRNSDirector Dealing
28th Mar 20187:00 amRNSFinal results for the year ended 31 December 2017
6th Feb 20187:00 amRNSMoUs signed with pioneers
19th Jan 20189:00 amRNSPublication of Scientific Paper
17th Jan 20187:00 amRNSPublication of Scientific Paper
6th Dec 20177:00 amRNSDirector Dealing
4th Dec 20177:00 amRNSNew Share Option Scheme and Grant to PDMR
1st Dec 20171:01 pmRNSDirectors' Dealing
28th Nov 20179:47 amRNSDirector Dealing
22nd Nov 20175:50 pmRNSHolding(s) in Company
20th Nov 201711:02 amRNSHolding(s) in Company
8th Nov 20178:11 amRNSCompletion of Acquisition, Appointment of Director
3rd Nov 20177:00 amRNSAcquisition of OpenIOLabs Limited
4th Oct 20177:00 amRNSChange of Adviser
12th Sep 20177:00 amRNSHalf-year Report
19th May 201711:34 amRNSResult of AGM
26th Apr 20177:00 amRNSDirectorate Changes
28th Mar 20177:00 amRNSFinal Results
16th Feb 20177:00 amRNSDigital Chemistry to be performed in space
31st Jan 20178:03 amRNSAdvisory Committee
31st Jan 20177:00 amRNSPresentation at Healthcare Conference
9th Jan 20177:00 amRNSDigitalGlasswareT
15th Sep 20167:00 amRNSHalf-year Report
12th May 201611:45 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.